Expertise in
61
conditions

Dr. Gary M. Reiss

Gastroenterology
Office
1151 Barataria Blvd Ste 4400, 
Marrero, LA 
Accepting New Patients
Offers Telehealth
Expertise in
61
conditions
Office
1151 Barataria Blvd Ste 4400, 
Marrero, LA 

Overview

Gary Reiss is a Gastroenterologist practicing medicine in Marrero, Louisiana.

Dr. Reiss is highly rated in 61 conditions, according to our data. His clinical expertise encompasses Jaundice, Familial Pancreatic Cancer, Pancreatic Cancer, Gastrectomy, and Gastrostomy.

He is actively involved in clinical research, participating in 7 clinical trials. Dr. Reiss is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in LA

Hospital Affiliations

Thibodaux Regional Medical Center
West Jefferson Medical Center
Ochsner Medical Center Acute
Touro Infirmary

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Magnolia Health
  • HMO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Primewell Health Services
  • HMO
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • POS
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Office
1151 Barataria Blvd Ste 4400, Marrero, LA 70072

Additional Areas of Focus

Dr. Reiss has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
Enrollment Status: Completed
Publish Date: August 19, 2026
Intervention Type: Drug
Study Drug: HM15211
Study Phase: Phase 2
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
Enrollment Status: Terminated
Publish Date: June 30, 2026
Intervention Type: Drug
Study Drug: Belapectin
Study Phase: Phase 2/Phase 3
The HepQuant SHUNT Liver Diagnostic Kit for Likelihood of Large Esophageal Varices: The SHUNT-V Study
The HepQuant SHUNT Liver Diagnostic Kit for Likelihood of Large Esophageal Varices: The SHUNT-V Study
Enrollment Status: Completed
Publish Date: April 11, 2025
Intervention Type: Combination product
Study Phase: Not Applicable
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2
A Phase 1 Study of the Safety and Tolerability of Single and Multiple Doses of KAN-101 in Patients With Celiac Disease (ACeD)
A Phase 1 Study of the Safety and Tolerability of Single and Multiple Doses of KAN-101 in Patients With Celiac Disease (ACeD)
Enrollment Status: Completed
Publish Date: August 06, 2024
Intervention Type: Drug
Study Drug: KAN-101
Study Phase: Phase 1
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Enrollment Status: Completed
Publish Date: July 08, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials
Similar Doctors
Expertise in
19
conditions
Dr. Janak N. Shah
Gastroenterology
Expertise in
19
conditions
Dr. Janak N. Shah
Gastroenterology
Referral may be required
Before you request

Ochsner Medical Center - New Orleans

1514 Jefferson Hwy 4th Floor, 
New Orleans, LA 
 (6.2 miles away)
504-842-4015
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Janak Shah joined Ochsner in 2015 and has served as the department chair of gastroenterology since 2019. He completed his training in gastroenterology and advanced endoscopy at the University of Pennsylvania. Before joining Ochsner, he spent over 10 years practicing in San Francisco, where he was the director of pancreatic and biliary endoscopy at California Pacific Medical Center and a clinical professor of medicine at the University of California. Dr. Shah is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Bile Duct Obstruction, Cholestasis, Bile Duct Stricture, Endoscopy, and Gallbladder Removal. Dr. Shah is board certified in American Board Of Internal Medicine - Gastroenterology. Dr. Shah is currently accepting new patients.

Expertise in
45
conditions
Dr. Brett M. Hymel
Gastroenterology
Expertise in
45
conditions
Dr. Brett M. Hymel
Gastroenterology
Referral may be required

Office

1151 Barataria Blvd Ste 4400, 
Marrero, LA 
 (0.1 miles away)
504-349-6401
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Brett Hymel is a Gastroenterologist practicing medicine in Marrero, Louisiana. Dr. Hymel is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Hereditary Pancreatitis, Portal Hypertension, Childhood Volvulus, Endoscopy, and Gastrectomy. Dr. Hymel is currently accepting new patients.

Expertise in
19
conditions
Dr. Ricardo V. Romero
Gastroenterology
Expertise in
19
conditions
Dr. Ricardo V. Romero
Gastroenterology
Referral may be required

Ochsner Clinic Foundation

1514 Jefferson Hwy, 
New Orleans, LA 
 (5.7 miles away)
504-842-4015
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ricardo Romero is a Gastroenterologist practicing medicine in New Orleans, Louisiana. Dr. Romero is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Bile Duct Obstruction, Cholestasis, Bile Duct Stricture, Endoscopy, and Pancreatectomy. Dr. Romero is currently accepting new patients.

Frequently Asked Questions about Dr. Gary M. Reiss

How do I make an appointment with Dr. Gary M. Reiss?

You can book an appointment with Dr. Gary M. Reiss by calling their office at 504-349-6401. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Gary M. Reiss a top-rated expert for Jaundice?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gary M. Reiss is classified as an Distinguished expert for Jaundice, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Gary M. Reiss specialize in?

While Dr. Gary M. Reiss is a Gastroenterology, they have specific expertise in Jaundice, Familial Pancreatic Cancer, and Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Gary M. Reiss accept my insurance?

Dr. Gary M. Reiss accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 504-349-6401 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Reiss's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 52 Advanced Conditions
    View All 59 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile